PADN-5: Ablation Reduces Pulmonary Hypertension in HF PADN-5: Ablation Reduces Pulmonary Hypertension in HF
Pulmonary artery denervation improved hemodynamic and clinical outcomes at 6 months, but design flaws in the sham-controlled study may muddy the results, a clinical trials expert cautions.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Cardiology News Source Type: news
More News: Cardiology | Clinical Trials | Health | Heart | Hypertension | Pulmonary Hypertension | Study